Company profile
Latest filings (excl ownership)
424B3
Prospectus supplement
13 Dec 10
EFFECT
Notice of effectiveness
10 Dec 10
UPLOAD
Letter from SEC
30 Nov 10
D
$400M in debt / Subsidiary Guarantees, sold $400M, 5 investors
6 Oct 10
8-K
Inverness Medical Innovations, Inc. Extends Exchange Offer for 7.875% Senior Notes due 2016
25 May 10
424B3
Prospectus supplement
23 Apr 10
EFFECT
Notice of effectiveness
21 Apr 10
Latest ownership filings
No filings